Healthcare Sector

MRNA

Market Tracker

$43.70
-3.16
(-6.74%)
5:20 am
Next Earnings: (est.) 08/04/23 12:00 am
  • MRNA (Selected)

    Moderna, Inc.

MRNA Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

MRNA Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

MRNA Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

MRNA Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

MRNA Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

MRNA Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
02/20/2026 CALL $47.00 7,476 +7,002 +1,477.22%
02/20/2026 PUT $47.01 7,000 +7,000
02/20/2026 PUT $45.00 4,634 +2,614 +129.41%
09/18/2026 CALL $46.00 1,652 +1,624 +5,800.00%
03/20/2026 PUT $30.00 9,014 +999 +12.46%
01/30/2026 PUT $47.00 1,778 +592 +49.92%
02/06/2026 CALL $46.00 6,977 -234 -3.25%
01/30/2026 PUT $55.00 1,513 -333 -18.04%
01/30/2026 CALL $55.00 2,175 -393 -15.30%
01/30/2026 CALL $46.00 1,827 -854 -31.85%
03/20/2026 CALL $47.00 14,026 -6,940 -33.10%
03/20/2026 PUT $47.01 13,340 -7,000 -34.41%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

MRNA Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 2.57% 9.93M 1.25B
Vanguard International Growth Fund 2.53% 9.77M 1.23B
Vanguard 500 Index Fund 1.98% 7.64M 961.76M
Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF 1.31% 5.08M 639.64M
Fidelity 500 Index Fund 0.94% 3.62M 456.08M
SPDR S&P 500 ETF Trust 0.92% 3.57M 449.61M
Vanguard Specialized-Health Care Fund 0.90% 3.49M 439.87M
Growth Fund Of America Inc 0.80% 3.11M 391.58M
iShares Core S&P 500 ETF 0.76% 2.95M 371.32M
Vanguard U.S. Growth Fund 0.75% 2.88M 362.55M

MRNA News

  • Stock Market Today, Jan. 20: ImmunityBio Soars Again After FDA Outlines Resubmission Path for ANKTIVA in Bladder Cancer

    01/26 06:02 pm

    The Motley Fool

    Read more
  • Hecla Mining, Moderna, And Micron Are Among the Top 10 Large-Cap Gainers Last Week (Jan. 19-Jan. 23): Are the Others in Your Portfolio?

    01/25 10:01 am

    Benzinga

    Read more
  • Lipid Nanoparticle Manufacturing Market: An 18.9% CAGR Market Driven by Nucleic Acid Therapies

    01/23 11:00 am

    GlobeNewswire Inc.

    Read more
  • Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Rise As BEA Pegs Q3 GDP At 4.4%— Microsoft, Moderna, Intel In Focus (UPDATED)

    01/22 09:46 am

    Benzinga

    Read more
  • Moderna Stock Rallies as Oncology Results Improve the Platform’s Value Case

    01/21 03:38 pm

    Investing.com

    Read more
  • Stocks Rebound On Trump's Remarks, Natural Gas Rockets: What's Moving Markets Wednesday?

    01/21 02:57 pm

    Benzinga

    Read more
  • Moderna Pops 17%—Is There Life in MRNA, Down 90% from COVID High?

    01/21 12:14 pm

    Investing.com

    Read more
  • Moderna–Merck Cancer Vaccine Shows Durable Benefit At 5 Years In High-Risk Melanoma

    01/20 05:21 pm

    Benzinga

    Read more
  • Silver Jumps To $89 After Soft CPI, JPMorgan Falls 3%: What's Moving Markets Tuesday?

    01/13 02:04 pm

    Benzinga

    Read more
  • My Top 5 Stocks to Buy in Early 2026

    01/07 05:15 am

    The Motley Fool

    Read more
  • Silver Jumps 6%, Platinum Up 8%, Palladium Up 11% As Metal Shock Erupts: What's Moving Markets Friday?

    12/26 01:47 pm

    Benzinga

    Read more
  • Nanobiotechnology Market to Hit USD 420.2 Billion by 2034, Fueled by 2025 Traffic Growth and Strategic Material & Product Innovations

    12/17 11:00 am

    GlobeNewswire Inc.

    Read more
  • XOMA Royalty Enters into Agreement to Acquire Generation Bio

    12/15 06:00 pm

    GlobeNewswire Inc.

    Read more
  • Immatics Presents IMA203CD8 PRAME Cell Therapy Data from Ongoing Dose Escalation and Shows Promising Initial Anti-tumor Activity in PRAME-Positive Tumors at ESMO-IO 2025 Congress

    12/11 08:00 am

    GlobeNewswire Inc.

    Read more
  • Seasonal Vaccines Market Accelerating Growth and Rising Opportunities Through 2035

    12/03 11:00 am

    GlobeNewswire Inc.

    Read more
  • Where Will Vertex Pharmaceuticals Be in 5 Years

    11/27 07:31 am

    The Motley Fool

    Read more
  • AI Just Sparked Biotech's Biggest Rally Since 2004 — Why Isn't Anyone Talking About It?

    11/25 04:14 pm

    Benzinga

    Read more
  • CytomX Therapeutics to Present at the Jefferies London Healthcare Conference

    11/13 09:00 am

    GlobeNewswire Inc.

    Read more
  • Immatics Achieves Clinical Proof-of-Concept of its Next-Generation TCR Bispecific (TCER®) Pipeline with Data on IMA402 (PRAME) and IMA401 (MAGEA4/8) and Announces Next Development Steps

    11/12 08:00 am

    GlobeNewswire Inc.

    Read more
  • CytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025

    10/30 08:00 am

    GlobeNewswire Inc.

    Read more
  • Moderna Stops CMV Program As Vaccine Falls Short In Preventing Infection

    10/23 10:26 am

    Benzinga

    Read more
  • Prediction: Moderna Will Soar Over the Next 5 Years. Here's 1 Reason Why.

    10/22 01:10 pm

    The Motley Fool

    Read more
  • These 3 Beaten-Down Healthcare Stocks Could Have Farther to Fall

    10/21 05:05 am

    The Motley Fool

    Read more
  • Stock Market Today: S&P 500, Nasdaq, Dow Jones Futures Rise— Micron, Bitmine, Coinbase In Focus

    10/20 05:15 am

    Benzinga

    Read more
  • Why Moderna Might Be a One-Hit Wonder

    10/15 04:08 pm

    The Motley Fool

    Read more
  • 6 Healthcare Stocks Positioned to Soar After Trump-Pfizer Deal

    10/02 12:15 pm

    Investing.com

    Read more
  • These 50%+ 'AI Dividends' Could Ruin Your Retirement

    10/02 05:21 am

    Investing.com

    Read more
  • Lyme Disease Market Growth Highlighted by Pipeline Advances and Expanding Patient Population | DelveInsight

    10/01 01:00 pm

    GlobeNewswire Inc.

    Read more
  • 2 Beaten-Down Stocks to Buy and Hold for a Decade

    09/30 07:30 am

    The Motley Fool

    Read more
  • Robert F. Kennedy Jr. Faces Impeachment Push From Haley Stevens Over 'Health Care Chaos' And Rising Costs: 'Enough Is Enough'

    09/26 12:08 am

    Benzinga

    Read more
  • Moderna's COVID-19 Vaccine Update Boosts Antibodies 16-Fold, Data Shows

    09/23 12:06 pm

    Benzinga

    Read more
  • Moderna Reports 8-Fold Jump In Antibodies With Updated Spikevax

    09/16 10:49 am

    Benzinga

    Read more
  • FDA Moves To Publicize Data On Pregnant Women's Covid Vaccine Side Effects

    09/10 01:21 pm

    Benzinga

    Read more
  • Global Industrial Biomanufacturing Market Report 2026-2036: Sustainability, Synthetic Biology, and Circular Economy Drive Growth

    09/10 04:39 am

    GlobeNewswire Inc.

    Read more
  • Untreated Metastatic or Unresectable Melanoma Clinical Trial Pipeline Expands as 10+ Companies Driving Innovation in Oncology Therapeutics Space | DelveInsight

    08/26 01:00 pm

    GlobeNewswire Inc.

    Read more
  • If You're in Your 30s, Consider Buying These 2 Healthcare Stocks

    08/17 09:30 am

    The Motley Fool

    Read more
  • CDC Shooting Linked To Suspect's COVID-19 Vaccine Beliefs, Former Staff Blame RFK Jr. Hostility Toward Agency

    08/12 01:41 pm

    Benzinga

    Read more
  • Global Cancer Vaccines Market to Surpass USD 15.00 Billion by 2032, Unlocking Over USD 10 Billion in New Growth Opportunities | MarketsandMarkets™.

    08/11 09:00 am

    GlobeNewswire Inc.

    Read more
  • CytomX (CTMX) Q2 Revenue Drops 26%

    08/07 06:29 pm

    The Motley Fool

    Read more
  • Moderna's Key Patent Win Overshadowed By Gloomy Outlook

    08/01 08:44 am

    Benzinga

    Read more
  • Alnylam Pharmaceuticals Q2 Earnings Crush Estimates, Stock Hits 52-Week High On Upbeat Forecast

    07/31 03:36 pm

    Benzinga

    Read more
  • Opinion: It's Time to Load Up on This Biotech Giant After Its 80% Crash

    07/14 08:30 pm

    The Motley Fool

    Read more
  • Delta Air, Moderna And Coinbase Are Among Top Large Cap Gainers Last Week (July 7-July 11): Are The Others In Your Portfolio?

    07/13 11:02 am

    Benzinga

    Read more
  • Where Will Moderna Be in 10 Years?

    07/05 05:10 am

    The Motley Fool

    Read more
  • Moderna's mRNA Flu Vaccine Outperforms Standard Shots

    06/30 09:51 am

    Benzinga

    Read more
  • Flu RNA Vaccines Market Research Report 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and Challenges

    06/20 10:59 am

    GlobeNewswire Inc.

    Read more
  • Is it Time to Dump Your Shares of Moderna?

    06/12 04:25 am

    The Motley Fool

    Read more
  • Moderna Beats Alnylam Appeal In COVID Vaccine Patent Case

    06/05 11:59 am

    Benzinga

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: